COVID-19 in heart transplant recipients

COVID-19 in heart transplant recipients

Introduction: After solid organ transplantation, patients require lifelong immunosuppressive medication, increasing susceptibility to COVID-19. We evaluated the clinical outcomes of heart transplant recipients in patients with COVID-19. Methods: We enrolled twenty-two COVID-19 cases of adult heart t...

Full description

Bibliographic Details
Main Authors: Sepideh Taghavi, Hoda Raffiei Jelodar, Ali Rafati, Nasim Naderi, Marzieh Mirtajaddini, Ahmad Amin, Leili Valizadeh, Razieh Omidvar, Monireh Kamali, Soroush Naseh
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2022-12-01
Series:Journal of Cardiovascular and Thoracic Research
Subjects:
sars-cov-2
covid-19
heart transplantation
immunosuppressive medication
Online Access:https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-14-258.pdf

Internet

https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-14-258.pdf

Similar Items